ARIPIPRAZOLE-ZP aripiprazole 30mg tablet blister pack

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

aripiprazole, Quantity: 30 mg

Disponible depuis:

Medis Pharma Pty Ltd

DCI (Dénomination commune internationale):

aripiprazole

forme pharmaceutique:

Tablet, uncoated

Composition:

Excipient Ingredients: microcrystalline cellulose; lactose monohydrate; maize starch; magnesium stearate; hyprolose

Mode d'administration:

Oral

Unités en paquet:

30

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

Aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.,Acute treatment of manic or mixed episodes associated with Bipolar I Disorder in adults as monotherapy and in combination with lithium or valproate;,Maintenance treatment of manic or mixed episodes in Bipolar I Disorder in adults as monotherapy.

Descriptif du produit:

Visual Identification: 9mm, round, biconvex, white uncoated tablets with 30 debossed on one side and ZL on the other side; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

Statut de autorisation:

Licence status A

Date de l'autorisation:

2014-10-29